|
|
 |
|
Viewing report
|
|
|
|
Romania Pharmaceuticals and Healthcare Report Q1 2012
Business Monitor International, Dec 2010, Pages: 107
The Romania Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts, pharmaceutical associations, government departments and regulatory bodies with independent forecasts and competitive intelligence on Romania's pharmaceuticals and healthcare industry.
While Romania's healthcare system faces immense challenges in the short to medium term, it is unlikely the provision of medical services will collapse due to budget shortfalls as sources in Romania predicted in early 2010. The country’s continuing economic stagnation and political uncertainty notwithstanding, BMI calculates that total pharmaceutical sales will grow from RON10.15bn (US$3.35bn) in 2009 to RON10.78bn (US$3.4bn) in 2010, making Romania the seventh-largest market in Emerging Europe.
Although government healthcare spending in Romania has faced significant cuts, private healthcare expenditure in the country is expanding rapidly, despite the poor economic environment. Part of this growth is due to the private substitution of healthcare provision due to restricted access to publicly-funded medical services. BMI forecasts the local currency growth rate for private healthcare expenditure to be 40.69% in 2010 – in stark contrast to government expenditure, which is expected to contract by 1.92% in 2010 following deep cuts in 2009.
Romania’s economy is expected to come up for air in Q410 and register growth, although the IMF forecasts a 2% contraction for 2010. Political uncertainty in the country is on the rise, with Emile Boc’s government avoiding a vote of no confidence in October 2010, with tens of thousands of protestors marching the streets. Some of the public sector workers protesting wage cuts of about 25% included healthcare professionals. Indeed, medical workers have been at the forefront with other key public employees also protesting in recent months.
The group of healthcare reforms being considered in late-2010 are expected to be implemented by the end of the year or early next year. This includes the introduction of the new system of patient co-payments, new methods for calculating drug reimbursement and the decentralisation of the hospital system. Minister of Health, Attila Cseke, reiterated and outlined reforms to Romania’s health insurance system expected to come into play in 2011. During a November 2010 visit to hospitals in Suceava Country, northeast Romania, Cseke extolled the features of the new system, which will continue to rely on contributions from policyholders but will allow counties to retain 50% of the contributions made by their residents. The remaining funds will continue to be collected centrally and will be redistributed among counties according to the number of people receiving healthcare services, the Ministry of Health said. The new system will be streamlined as a result of the reforms, Cseke argued, providing greater efficiency in allocating funds where needed, increasing transparency and offering stronger decentralisation. BMI views these developments positively. They will contribute to the financial sustainability of the public healthcare system. In particular, the patient co-payments system will encourage patients to pay slightly more for private treatment, owing to the fees effectively discounting such practices. BMI expects Romania’s total healthcare expenditure to grow from RON23.47bn (US$7.75bn) in 2009 to RON24.77bn (US$7.81bn) in 2010.
Product samples
A sample for this product is available. Please Login/Register to download this sample.
Customers who bought this item also bought
Romania Pharmaceuticals and Healthcare Report Q1 2012
Romania Pharmaceuticals and Healthcare Report Q1 2012
Romania Pharmaceuticals and Healthcare Report Q1 2012
Romania Pharmaceuticals and Healthcare Report Q1 2012
Romania Pharmaceuticals and Healthcare Report Q1 2012
Romania Pharmaceuticals and Healthcare Report Q1 2012
Romania Pharmaceuticals and Healthcare Report Q1 2012
Slovakia Pharmaceuticals and Healthcare Report Q1 2011
Kazakhstan Pharmaceuticals and Healthcare Report Q1 2011
Bulgaria Pharmaceuticals and Healthcare Report Q1 2011
|
|
|
|
